Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-11T22:34:24.527Z Has data issue: false hasContentIssue false

Brachial plexus block with ropivacaine and bupivacaine for the formation of arteriovenous fistula in patients with end-stage renal failure

Published online by Cambridge University Press:  02 June 2005

H. D. Misiolek
Affiliation:
Department of Anaesthesiology and Intensive Therapy, Silesian School of Medicine, Zabrze, Silesia, Poland
H. J. Kucia
Affiliation:
Department of Anaesthesiology and Intensive Therapy, Silesian School of Medicine, Zabrze, Silesia, Poland
P. Knapik
Affiliation:
Department of Anaesthesiology and Intensive Therapy, Silesian School of Medicine, Zabrze, Silesia, Poland
M. M. Werszner
Affiliation:
Department of Anaesthesiology and Intensive Therapy, Silesian School of Medicine, Zabrze, Silesia, Poland
J. W. Karpe
Affiliation:
Department of Anaesthesiology and Intensive Therapy, Silesian School of Medicine, Zabrze, Silesia, Poland
J. Gumprecht
Affiliation:
Department of Internal Diseases, Nephrology and Diabetology, Silesian School of Medicine, Zabrze, Silesia, Poland
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
© 2005 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rodriguez J, Quintela O, Lopez-Rivadula M, Barcena M, Diz C, Alvarez J. High doses of mepivacaine for brachial plexus block in patients with end-stage chronic renal failure. A pilot study. Eur J Anesthesiol 2001; 18: 171176.Google Scholar
McClellan KJ, Faulds D. Ropivacaine: an update of its use in regional anaesthesia. Drugs 2000; 60: 10651093.Google Scholar
Klein SM, Greengrass RA, Steele SM, et al. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block. Anesth Analg 1998; 87: 13161391.Google Scholar
McGlade DP, Kalpokas MV, Mooney PH. A comparison of 0.5% ropivacaine and 0.5% bupivacaine for axillary brachial plexus anaesthesia. Anaesth Intensive Care 1998; 26: 515520.Google Scholar
Raeder JC, Drosdahl S, Klaastad O, et al. Axillary brachial plexus block with ropivacaine 7.5 mg/ml. A comparative study with bupivacaine 5 mg/ml. Acta Anesthesiol Scand 1999; 43: 794798.Google Scholar
Pere P, Salonen M, Jokinen M, Rosenberg PH, Neuvonen PJ, Haasio J. Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. Anesth Analg 2003; 96: 563569.Google Scholar